According to a research report titled ‘Growth Hormone Market Size By Product (Powder, Solvent), By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small For Gestational Age, Prader-Willi Syndrome), By Distribution Channel (Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, growth hormone market is estimated to record substantial growth over the forecast period 2021-2027.
 

Report findings state that growth hormone market is largely driven by increasing prevalence of hormonal disorders and rising number of regulatory approvals in this field. Moreover, increasing use of growth hormone therapy for the treatment of small for gestational age (SGA) and other disorders such as obesity is projected to stimulate industry growth during the study period.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793253/
 

For the record, recent studies have revealed that COVID-19 infection during pregnancy have led to higher rates of preterm delivery, with over 15.5% of cases of SGA, indicating an increased demand for growth hormone.
 

Based on product, the growth hormone market is split into solvent and powder. Among these, the solvent sub-segment is estimated to register 8% CAGR throughout the analysis period due to increasing circulation of drugs across the world.
 

By application ambit, the industry is arrayed into Small for Gestational Age (SGA), growth hormone deficiency, idiopathic short stature, Turner syndrome, and Prader-Willi syndrome. Among these, the small for gestational age (SGA) sub-segment was valued at USD 214 million in 2020 due to increased use of hormonal therapy for the disease. Moreover, growth hormone therapy is being extensively used for the treatment of Prader-Willi syndrome (PWS).
 

Speaking of the distribution channels, research literature classifies the growth hormone industry into hospital pharmacies, online med stores and retail pharmacies. Of these, the hospital pharmacy sub-segment accounted for more than 55% market share in 2020, amplified by the high volume of hospital visits and prescription rates.
 

From a regional frame of reference, Latin America market is slated to garner 6% CAGR during the forecast period. This can be attributed to rising awareness regarding growth disorders and the available treatment options.
 

Major players in growth hormone market sphere are Genentech Inc. (Roche Group), Ferring B.V., LG Chem Ltd., Anhui Anke Biotechnology (Group) Co. Ltd., Ipsen S.A., The Merck Group, Eli Lily and Company, Novartis International AG, Pfizer Inc., and Novo Nordisk A/S.